Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

Apollo Medical Holdings, Inc.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - Care FacilitiesSector: Healthcare

Fair Value Summary

Current Price$40.82
5Y Range433.14 – 658.65
5Y Selected545.90
(-) Safety Margin78.06%
5Y Buy Price$119.77
Upside (to Buy Price)193.41%
10Y Range518.27 – 775.88
10Y Selected647.08
(-) Safety Margin78.06%
10Y Buy Price$141.97
Upside (to Buy Price)247.79%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9785
Revenue R2 (10Y)0.8543
Net Income R2 (5Y)0.2943
Net Income R2 (10Y)0.4841
EBITDA R2 (5Y)0.1336
EBITDA R2 (10Y)0.0034
FCF R2 (5Y)0.0752
FCF R2 (10Y)0.5029
Safety Score0.2194

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth19.42%17.70%15.99%14.28%12.56%10.85%9.14%7.43%5.71%4.00%
Revenue2,429.582,859.713,317.003,790.604,266.894,729.925,162.195,545.535,862.356,096.84
EBITDA1,640.541,930.982,239.762,559.552,881.153,193.813,485.693,744.543,958.464,116.80
D&A-48.42-56.99-66.10-75.54-85.04-94.26-102.88-110.52-116.83-121.50
EBIT1,592.121,873.992,173.652,484.002,796.123,099.553,382.813,634.023,841.633,995.30
Pro forma Taxes-644.11-758.14-879.37-1,004.93-1,131.19-1,253.95-1,368.55-1,470.18-1,554.17-1,616.33
NOPAT948.011,115.851,294.281,479.081,664.921,845.602,014.262,163.842,287.462,378.96
Capital Expenditures-29.02-34.16-39.62-45.27-50.96-56.49-61.65-66.23-70.02-72.82
NWC Investment23.4125.4927.1028.0628.2227.4425.6122.7218.7713.90
(+) D&A48.4256.9966.1075.5485.0494.26102.88110.52116.83121.50
Free Cash Flow990.821,164.171,347.871,537.411,727.221,910.812,081.102,230.842,353.052,441.54
Diluted Shares Outstanding47,523,077.0047,523,077.0047,523,077.0047,523,077.0047,523,077.0047,523,077.0047,523,077.0047,523,077.0047,523,077.0047,523,077.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.451.452.463.464.465.466.467.468.46
Valuation Date1/17/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.43%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF982.231,119.441,187.991,240.971,277.911,295.851,293.641,271.081,228.901,168.78
Raw: 26,520.45
18,785.66
Raw: 37,488.53
17,181.46

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value24,594.2029,248.25
(-) Net Debt-143.46-143.46
Equity Value24,737.6529,391.71
(/) Shares Out47.5247.52
Fair Value$520.54$618.47
(-) Safety Margin78.06%78.06%
Buy Price$114.21$135.69
Current Price$40.82$40.82
Upside (to Buy Price)179.78%232.42%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.93%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF981.341,114.851,172.381,213.421,238.201,244.171,230.771,198.321,148.041,081.96
Raw: 21,546.15
14,720.52
Raw: 30,457.00
12,863.03

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value20,440.7024,486.48
(-) Net Debt-143.46-143.46
Equity Value20,584.1624,629.94
(/) Shares Out47.5247.52
Fair Value$433.14$518.27
(-) Safety Margin78.06%78.06%
Buy Price$95.03$113.71
Current Price$40.82$40.82
Upside (to Buy Price)132.80%178.56%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.93%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.970.890.830.760.710.650.600.560.52
PV UFCF983.141,124.081,203.961,269.401,319.281,350.171,360.341,348.981,316.291,263.48
Raw: 34,380.72
25,257.89
Raw: 48,599.57
24,189.46

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value31,157.7536,728.60
(-) Net Debt-143.46-143.46
Equity Value31,301.2136,872.05
(/) Shares Out47.5247.52
Fair Value$658.65$775.88
(-) Safety Margin78.06%78.06%
Buy Price$144.51$170.23
Current Price$40.82$40.82
Upside (to Buy Price)254.01%317.02%

Reverse DCF: Market Implied Growth

Current Price$40.82
WACC Used9.1%
IMPLIED REVENUE GROWTH95.35%
Metric2027202820292030203120322033203420352036
Implied Revenue6,313.9912,334.3224,094.9947,069.3691,949.58179,622.70350,891.36685,463.201,339,046.332,615,815.23
Constant Implied Growth95.35%95.35%95.35%95.35%95.35%95.35%95.35%95.35%95.35%95.35%
Implied Free Cash Flow0.631.232.414.719.1917.9635.0968.55133.90261.58
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF0.591.001.783.195.7210.2318.3332.8158.76105.21

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$18.4134.04%$16.68-9.39%
20182018-12-31$19.8521.44%$29.8050.15%
20172017-03-31$9.0010.41%$-33.07-467.46%
20162016-03-31$7.507.92%$-6.98-193.13%
20152015-03-31$5.0011.33%$-2.42-148.38%
20142014-03-31$5.5024.81%$-13.23-340.58%
20132013-01-31$6.3042.53%$-0.11-101.75%
20122012-01-31$1.4841.12%$-10.11-782.91%
20112011-01-31$1.6040.30%$-7.28-555.13%
20102010-01-31$0.8333.79%$-7.56-1,012.55%
20092009-01-31$2.0022.24%$-10.05-602.27%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$636.80
Median
$621.76
10th Percentile
$517.00
90th Percentile
$770.09

Fair Value Distribution

$410.94 - $452.89
9
$452.89 - $494.84
39
$494.84 - $536.79
114
$536.79 - $578.74
163
$578.74 - $620.69
172
$620.69 - $662.64
154
$662.64 - $704.59
120
$704.59 - $746.54
81
$746.54 - $788.49
75
$788.49 - $830.44
28
$830.44 - $872.39
14
$872.39 - $914.34
13
$914.34 - $956.28
8
$956.28 - $998.23
3
$998.23 - $1,040.18
3
$1,040.18 - $1,082.13
1
$1,082.13 - $1,124.08
2
$1,124.08 - $1,166.03
0
$1,166.03 - $1,207.98
0
$1,207.98 - $1,249.93
1